@misc{indiciaeecb4ba348d02,
  title = {The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 B.1.351 and other variants of concern in preclinical studies.},
  author = {Spencer, A. J. and Morris, S. and Ulaszewska, M. and Powers, C. and Kaliath, R. and Bissett, C. D. and Truby, A. and Thakur, N. and Newman, J. and Allen, E. R. and Lui, C. and Dejnirattisai, W. and Mongkolsapaya, J. and Davies, H. and Donnellan, F. R. and Pulido, D. and Peacock, T. P. and Barclay, W. S. and Bright, H. and Ren, K. and Screaton, G. and McTammy, P. and Bailey, D. and Gilbert, S. C. and Lambe, T.},
  year = {2021},
  doi = {10.1101/2021.06.08.447308},
  url = {https://www.biorxiv.org/content/10.1101/2021.06.08.447308v1},
  note = {Source identifier: 10.1101/2021.06.08.447308}
}